IRIS Accounts Production v25.1.0.734 07193336 director 1.4.24 31.3.25 31.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh071933362024-03-31071933362025-03-31071933362024-04-012025-03-31071933362023-03-31071933362023-04-012024-03-31071933362024-03-3107193336ns15:EnglandWales2024-04-012025-03-3107193336ns14:PoundSterling2024-04-012025-03-3107193336ns10:Director12024-04-012025-03-3107193336ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3107193336ns10:SmallEntities2024-04-012025-03-3107193336ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3107193336ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3107193336ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107193336ns10:FullAccounts2024-04-012025-03-310719333612024-04-012025-03-3107193336ns10:CompanySecretary12024-04-012025-03-3107193336ns10:RegisteredOffice2024-04-012025-03-3107193336ns5:CurrentFinancialInstruments2025-03-3107193336ns5:CurrentFinancialInstruments2024-03-3107193336ns5:ShareCapital2025-03-3107193336ns5:ShareCapital2024-03-3107193336ns5:SharePremium2025-03-3107193336ns5:SharePremium2024-03-3107193336ns5:RetainedEarningsAccumulatedLosses2025-03-3107193336ns5:RetainedEarningsAccumulatedLosses2024-03-310719333612024-04-012025-03-3107193336ns5:NetGoodwill2024-04-012025-03-3107193336ns5:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107193336ns5:PlantMachinery2024-04-012025-03-3107193336ns5:ComputerEquipment2024-04-012025-03-3107193336ns5:NetGoodwill2024-03-3107193336ns5:NetGoodwill2025-03-3107193336ns5:NetGoodwill2024-03-3107193336ns5:LeaseholdImprovements2024-03-3107193336ns5:PlantMachinery2024-03-3107193336ns5:FurnitureFittings2024-03-3107193336ns5:ComputerEquipment2024-03-3107193336ns5:LeaseholdImprovements2024-04-012025-03-3107193336ns5:FurnitureFittings2024-04-012025-03-3107193336ns5:LeaseholdImprovements2025-03-3107193336ns5:PlantMachinery2025-03-3107193336ns5:FurnitureFittings2025-03-3107193336ns5:ComputerEquipment2025-03-3107193336ns5:LeaseholdImprovements2024-03-3107193336ns5:PlantMachinery2024-03-3107193336ns5:FurnitureFittings2024-03-3107193336ns5:ComputerEquipment2024-03-3107193336ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3107193336ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31071933361ns10:Director12024-03-31071933361ns10:Director12023-03-31071933361ns10:Director12024-04-012025-03-31071933361ns10:Director12023-04-012024-03-31071933361ns10:Director12025-03-31071933361ns10:Director12024-03-31
REGISTERED NUMBER: 07193336 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

NORTON IMPLANTS LIMITED

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


NORTON IMPLANTS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2025







DIRECTOR: Dr M R Norton





SECRETARY: Mrs L J Norton





REGISTERED OFFICE: 4th Floor
Charles House
108-110 Finchley Road
London
NW3 5JJ





REGISTERED NUMBER: 07193336 (England and Wales)





ACCOUNTANTS: Numera Partners LLP
4th Floor
Charles House
108-110 Finchley Road
London
NW3 5JJ

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

BALANCE SHEET
31 MARCH 2025

31.3.25 31.3.24
Notes £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 387,424 391,410
387,424 391,410

CURRENT ASSETS
Stocks 1,900 2,100
Debtors 6 156,561 298,812
Cash at bank 358,988 318,772
517,449 619,684
CREDITORS
Amounts falling due within one year 7 168,093 150,113
NET CURRENT ASSETS 349,356 469,571
TOTAL ASSETS LESS CURRENT
LIABILITIES

736,780

860,981

CAPITAL AND RESERVES
Called up share capital 100 100
Share premium 750,000 750,000
Retained earnings (13,320 ) 110,881
SHAREHOLDERS' FUNDS 736,780 860,981

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 May 2025 and were signed by:





Dr M R Norton - Director


NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1. STATUTORY INFORMATION

Norton Implants Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£) and rounded to the nearest £.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern
After reviewing the company's forecasts and projections, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company, therefore continues to adopt the going concern policy in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilites that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revisions affects both current and future periods.

Turnover
Turnover represents invoiced sales of goods and services.

Goodwill
Goodwill is the difference between amounts paid on the acquisition of a business and the fair value of the identifiable assets and liabilities. It is amortised to the profit and loss account over its estimated useful life.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilites once they are no longer at the discretion of the company.

Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is higher of fair value less costs to sell and value in use. In assessing value in use, the estimated cash flows are discounted to their present value using a pre tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of asset (or cash-generating) unit is estimated to be less than its carrying amount, the carrying amount of the assets (or cash generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount , in which case the reversal of the impairment loss is treated as a revaluation increase.

Financial instruments
The company has elected to apply the provisions of section 11 'basic financial instruments' and section 12 'other financial instruments issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to contractual provisions of the instruments.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic Financial instruments
Basic financial instruments, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairments at each reporting date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the assets original effective interest rate. The impairment loss is recognised in the profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets
Financial assets are recognised only when the contractual rights to the cashflows form the asset expire of are settled, or when the company transfers the financial assets and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

2. ACCOUNTING POLICIES - continued

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt , are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 4 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2024
and 31 March 2025 750,000
AMORTISATION
At 1 April 2024
and 31 March 2025 750,000
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 -

NORTON IMPLANTS LIMITED (REGISTERED NUMBER: 07193336)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Computer
property machinery fittings equipment Totals
£    £    £    £    £   
COST
At 1 April 2024 191,058 175,167 179,963 3,160 549,348
Additions - - - 1,481 1,481
At 31 March 2025 191,058 175,167 179,963 4,641 550,829
DEPRECIATION
At 1 April 2024 - 157,148 - 790 157,938
Charge for year - 4,504 - 963 5,467
At 31 March 2025 - 161,652 - 1,753 163,405
NET BOOK VALUE
At 31 March 2025 191,058 13,515 179,963 2,888 387,424
At 31 March 2024 191,058 18,019 179,963 2,370 391,410

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors - 14,958
Other debtors 156,561 283,854
156,561 298,812

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Taxation and social security 163,296 145,441
Other creditors 4,797 4,672
168,093 150,113

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25 31.3.24
£    £   
Dr M R Norton
Balance outstanding at start of year 265,839 202,744
Amounts advanced 1,053,016 817,887
Amounts repaid (1,171,292 ) (754,792 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 147,563 265,839

This balance was repaid after the year end.